They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

In the fierce race to dominate the weight loss drug market, global pharmaceutical giant Eli Lilly announced on Wednesday that ...

A cardiovascular doctor calls this "the first trial" to test this specific link between obesity medication and this heart ...

Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising ...

The National Health Service (NHS) in England will make a new weight loss drug available next year – but fewer than 10 per ...

Wegovy, Ozempic, Mounjaro and retatrutide – the ‘miracle’ drugs are booming. We assess whether they’re safe and how they ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by ...

Tirzepatide, a weight loss drug, shows promise in preventing diabetes by improving insulin sensitivity and aiding in weight ...

The Cool Ridge, West Virginia, woman shed 60 pounds and lowered her blood pressure nearly 60 points ... for those on the ...

but not diastolic blood pressure, was reduced from four weeks of treatment. Inflammation, as measured by high sensitivity C reactive protein, was reduced by 24 weeks, and those taking tirzepatide even ...